Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus
Conditions
- Recurrent Uterine Corpus Sarcoma
- Uterine Carcinosarcoma
Interventions
- OTHER: Laboratory Biomarker Analysis
- DRUG: Thalidomide
Sponsor
National Cancer Institute (NCI)
Collaborators